|
| |
| | 67026 | | 29.03.2019 | | Eli Lilly (Suisse) SA | | | | | | | | | | | | 02.05.10. | | | | 02.05.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Emgality 120 mg | solution injectable en stylo prérempli | Injection solution in prefilled syringe (Galcanezumabum 120 mg/ml) | N02CD02 | CI |
|
|
|